NRx Pharmaceuticals, Inc. (NRXPW) Financials

$0.10

$0.04 (61.74%)
Last update: 11:13 AM EST
Day's range
$0.06
Day's range
$0.08
$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80M-$100M-$100MEarning201820182019201920202020202120212022202220232023202420246%6%5%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

NRXPW Income statement / Annual

Last year (2024), NRx Pharmaceuticals, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, NRx Pharmaceuticals, Inc.'s net income was -$25.13 M. See NRx Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $5.00 K $5.00 K $4.00 K $2.00 K $907.41 K $0.00 $1.01 M $0.00
Gross Profit -$5.00 K -$5.00 K -$4.00 K -$2.00 K -$907.00 K $0.00 -$1.01 M $0.00
Gross Profit Ratio 0 0 0 0 0 0 0 0
Research and Development Expenses $6.20 M $13.37 M $17.03 M $20.26 M $10.63 M $0.00 $0.00 $0.00
General & Administrative Expenses $13.51 M $14.22 M $27.37 M $74.94 M $11.44 M $2.77 K $0.00 $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $13.51 M $14.21 M $27.37 M $74.94 M $11.44 M $2.77 K $1.01 M $0.00
Other Expenses $0.00 $250.00 K $0.00 -$771.00 K -$10.16 M $0.00 $0.00 $0.00
Operating Expenses $19.70 M $27.58 M $44.40 M $94.43 M $11.90 M $713.19 K $0.00 $0.00
Cost And Expenses $19.70 M $27.59 M $44.40 M $94.43 M $51.72 M $0.00 $1.01 M $0.00
Interest Income $44.00 K $494.00 K $249.00 K $18.00 $56.00 $1.21 M $1.09 M $0.00
Interest Expense $1.08 M $120.00 K $0.00 $18.00 K $56.00 K $0.00 $0.00 $0.00
Depreciation & Amortization $5.00 K $5.00 K $4.00 K $2.00 K $2.00 K $0.00 $0.00 $52.52 K
EBITDA -$24.04 M -$30.03 M -$39.75 M -$93.04 M -$51.72 M -$713.00 K $82.41 K -$105.00 K
EBITDA Ratio 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net -$6.62 M -$2.57 M $4.58 M $22.73 M $490.84 K $1.21 M $1.09 M -$105.00 K
Income Before Tax -$25.13 M -$30.16 M -$39.75 M -$93.06 M -$51.78 M $492.63 K $82.41 K -$105.00 K
Income Before Tax Ratio 0 0 0 0 0 0 0 0
Income Tax Expense $0.00 -$9.00 K $0.00 $0.00 -$39.43 M $84.21 K $16.31 K $0.00
Net Income -$25.13 M -$30.15 M -$39.75 M -$93.06 M -$51.78 M $408.43 K $66.10 K -$105.00 K
Net Income Ratio 0 0 0 0 0 0 0 0
EPS -2.39 -3.98 -0.6 -7.44 -1.51 0.8 0.0741 -0.12
EPS Diluted -2.39 -3.98 -0.6 -7.44 -1.51 0.8 0.0741 -0.12
Weighted Average Shares Out $10.52 M $7.58 M $65.77 M $46.92 M $546.59 K $508.84 K $892.50 K $903.55 K
Weighted Average Shares Out Diluted $10.52 M $7.58 M $65.77 M $46.92 M $546.59 K $508.84 K $892.50 K $903.55 K
Link